Our results highlight the concept that cotreatment of cisplatin and SFI prompted cell cycle arrest and mediated cell apoptosis events that were part of the upregulation of Mfn2, suggesting the role of Mfn2 in chemoresistance in cancer cells. Here, MFN2 is linked to cancer.